Is CRISPR the Answer to Treating Progeria?
source: pixabay.com

Is CRISPR the Answer to Treating Progeria?

According to BioSpace, recent research has demonstrated that CRISPR gene editing could be the answer to treating progeria, or Hutchinson-Gilford progeria syndrome. The Broad Institute and NIH have collaborated to…

Continue Reading Is CRISPR the Answer to Treating Progeria?

FDA Approves Progeria Treatment

As of November 20, Zokinvy has been approved by the FDA for the treatment of Hutchinson-Gilford progeria syndrome (progeria) and a few other progeroid laminopathies in patients aged one year…

Continue Reading FDA Approves Progeria Treatment
Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria
jniittymaa0 / Pixabay

Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria

The US Food and Drug Administration and Eiger BioPharmaceuticals, Inc. have met to discuss lonafarnib, a drug being investigated as a potential treatment for Hutchinson-Gilford Progeria Syndrome. For more detailed…

Continue Reading Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria
The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria
jarmoluk / Pixabay

The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria

According to a story from EurekAlert, a recent study published in the journal Pediatric Research reveals new protein biomarkers that researchers can use to evaluate how patients with progeria have reacted…

Continue Reading The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria